Keynote Presentation: Leveraging Clinical Polyclonal Tregs for the Development of Modified & Engineered Tregs
Time: 9:30 am
day: Day Two AM
Details:
- Harnessing effective data from clinically derived polyclonal Tregs
- Showcasing long-term clinical Type 1 Diabetes data
- Utilizing polyclonal Tregs to shape the next generation of Treg therapies
